Domů › Rakovina prostaty › Oklahoma › Oklahoma City
Klinické studie Rakovina prostaty v Oklahoma City, OK
21 studií pro Rakovina prostaty hledá účastníky v lokalitách v Oklahoma City a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Probíhá náborFáze 1/2
- University of Oklahoma, Oklahoma City
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
Probíhá náborFáze 3
- University of Oklahoma Health Sciences Center, Oklahoma City
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Probíhá náborObservační studieVítáni zdraví dobrovolníci
- Mercy Hospital Oklahoma City, Oklahoma City
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Probíhá náborFáze 2
- University of Oklahoma Health Sciences Center, Oklahoma City
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Probíhá náborFáze 2
- University of Oklahoma Health Sciences Center, Oklahoma City
Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer
Probíhá náborFáze 3
- Oklahoma Proton Center, Oklahoma City
Protoacoustic Imaging For 3D Mapping
Probíhá náborObservační studie
- OU Health Stephenson Cancer Center, Oklahoma City
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Probíhá náborFáze 3
- Hightower Clinical, Oklahoma City
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
Probíhá náborFáze 3
- University of Oklahoma Health Sciences Center, Oklahoma City
The Vanguard Study: Testing a New Way to Screen for Cancer
Probíhá náborVítáni zdraví dobrovolníci
- University of Oklahoma Health Sciences Center, Oklahoma City
Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno)
Probíhá náborObservační studie
- OU Health Stephenson Cancer Center, Oklahoma City
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Probíhá náborFáze 3
- University of Oklahoma Health Sciences Center, Oklahoma City
- Mercy Hospital Oklahoma City, Oklahoma City
A Study of DM002 in Patients With Advanced Solid Tumors
Probíhá náborFáze 1/2
- University of Oklahoma Health Sciences Center, Oklahoma City
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Probíhá náborFáze 3
- University of Oklahoma Health Sciences Center, Oklahoma City
Using a mHealth App to Improve Quality-of-Life Outcomes in Black Prostate Cancer Survivors
Probíhá nábor
- University of Oklahoma HSC, Oklahoma City
Carboplatin Chemotherapy Before Surgery for People With High-Risk Prostate Cancer and an Inherited BRCA1 or BRCA2 Gene Mutation
Probíhá náborFáze 2
- University of Oklahoma Health Sciences Center, Oklahoma City
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
Probíhá náborFáze 3
- University of Oklahoma Health Sciences Center, Oklahoma City
Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer
Probíhá náborObservační studie
- OU Health Stephenson Cancer Center, Oklahoma City
Connect2Care: Prostate Cancer Education and Screenings for African American Men
Probíhá nábor
- TSET Health Promotion Research Center, Oklahoma City
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
Probíhá náborFáze 3
- University of Oklahoma Health Sciences Center, Oklahoma City
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
Probíhá náborFáze 1
- Exelixis Clinical Site #13, Oklahoma City
Studie Rakovina prostaty v jiných městech
- New York City, NY103 studií
- Houston, TX76 studií
- Los Angeles, CA61 studií
- Boston, MA59 studií
- St. Louis, MO46 studií
- Chicago, IL45 studií
- San Francisco, CA45 studií
- Philadelphia, PA44 studií
- Baltimore, MD43 studií
- Nashville, TN42 studií
- Seattle, WA42 studií
- Washington, DC38 studií
Další studie v Oklahoma City
- Nemalobuněčný plicní karcinom28 studií
- Rakovina vaječníků28 studií
- Rakovina endometria25 studií
- Kolorektální karcinom22 studií
- Rakovina plic19 studií
- Rakovina prsu17 studií
- Metastatický karcinom15 studií
- Rakovina (všechny typy)14 studií
- Akutní myeloidní leukemie14 studií
- Squamózní buněčný karcinom hlavy a krku13 studií
- Rakovina slinivky břišní11 studií
- Rakovina močového měchýře11 studií
Zdroj: ClinicalTrials.gov, data načtena 5. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.